An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT03338790 · COMPLETED
Trial details
- NCT number
- NCT03338790
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2021-01-13
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.